Table of contents
October 2008 Volume 4 No 10
Editorial
Approaching a renaissance in coma research responsibly
523doi:10.1038/ncpneuro0916 | Full Text | PDF (131K)
Research Highlights
MRZ reaction could distinguish patients with NMO from those with MS
524Antisense RNA upregulates
-secretase 1 in Alzheimer disease
524Metabolic syndrome predicts resistance to thrombolysis in stroke patients
525Disrupted calcium homeostasis implicated in Alzheimer disease pathogenesis
525Potential therapeutic role of microRNAs in glioblastoma multiforme
526Does plaque clearance halt progression of Alzheimer disease?
526Practice Points
Neuroleptic discontinuation during dementia care: a recent trial and its implications for practice
528doi:10.1038/ncpneuro0884 | Full Text | PDF (163K)
Pushing or pulling to predict falls in Parkinson disease?
530doi:10.1038/ncpneuro0912 | Full Text | PDF (161K)
Optic neuritis and the risk of multiple sclerosis—what can we learn from a brain MRI scan?
532doi:10.1038/ncpneuro0911 | Full Text | PDF (157K)
Kleine–Levin syndrome: a disease in its own right?
534doi:10.1038/ncpneuro0900 | Full Text | PDF (164K)
Transcranial ultrasound in the diagnosis of Parkinson's disease
536doi:10.1038/ncpneuro0859 | Full Text | PDF (158K)
The hyperdense internal carotid artery sign: a specific but limited marker of occlusion in stroke
538doi:10.1038/ncpneuro0899 | Full Text | PDF (156K)
Eye signs in patients with parkinsonism: do they predict the development of multiple system atrophy?
540doi:10.1038/ncpneuro0885 | Full Text | PDF (164K)
Viewpoints
Neuroimaging, impaired states of consciousness, and public outreach
542Functional neuroimaging is emerging as a novel tool to evaluate patients with disorders of consciousness. This Viewpoint looks at one of the most vexing ethical challenges resulting from this development: how should doctors react if families request a functional MRI scan for a loved one who is in a limited state of consciousness?
doi:10.1038/ncpneuro0888 | Full Text | PDF (174K)
The changing spectrum of coma
544The concept of consciousness has evolved as technology has progressed, and our understanding of coma and disorders of consciousness has deepened accordingly. In this Viewpoint, Steven Laureys traces the beginnings of coma research and shows how the introduction of functional neuroimaging has revolutionized this field.
doi:10.1038/ncpneuro0887 | Full Text | PDF (194K)
Reviews
Neurological manifestations of Waldenström macroglobulinemia
547Waldenstrom's macroglobulinemia—a condition that is characterized by overproduction of IgM antibodies and most commonly occurs in lymphoplasmacytic lymphoma—is often accompanied by nervous system complications, such as peripheral neuropathy or complications related to serum hyperviscosity. This Review provides an overview of the diagnosis and treatment of such neurological manifestations.
doi:10.1038/ncpneuro0917 | Full Text | PDF (593K)
B cells as therapeutic targets in autoimmune neurological disorders
557Over the past few years, evidence has accumulated to indicate that B cells have a pivotal role in the pathogenesis of various autoimmune neurological disorders, including multiple sclerosis, myasthenia gravis and inflammatory myopathies. In this article, Marinos Dalakas highlights the roles of B cells in these and other autoimmune disorders, and summarizes the experience to date with anti-B-cell therapies, focusing particularly on the B-cell-depleting monoclonal antibody rituximab.
doi:10.1038/ncpneuro0901 | Full Text | PDF (756K)

McArdle disease: what do neurologists need to know?
568doi:10.1038/ncpneuro0913 | Full Text | PDF (419K)

